Benitec Biopharma Inc. (BNTC) revenue
Benitec Biopharma Inc. (BNTC) reported revenue of $75.00K in fiscal 2023 (the year ended June 30, 2023). That is 2.7% higher than the $73.00K of fiscal 2022. Figures as of 18 Nov 2026, 07:12 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Revenue, fiscal 2023
- $75.00K
- Change on fiscal 2022
- +2.7%
- Highest on record
- $12.20Mfiscal 2019
- Lowest on record
- $59.00Kfiscal 2021
- Fiscal years on record
- 52019–2023
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Benitec Biopharma Inc. revenue, in more detail
Across the 5 fiscal years on record (2019–2023), the highest was $12.20M in fiscal 2019 and the lowest $59.00K in fiscal 2021.
Revenue by fiscal year
Benitec Biopharma Inc. revenue, year by year
| Fiscal year | Revenue | Change | Year ended |
|---|---|---|---|
| 2023 | $75.00K | 2.7% up | |
| 2022 | $73.00K | 23.7% up | |
| 2021 | $59.00K | 42.2% down | |
| 2020 | $102.00K | 99.2% down | |
| 2019 | $12.20M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
How to read it
Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.
Benitec Biopharma Inc., figure by figure
- Benitec Biopharma Inc. market cap
- Benitec Biopharma Inc. earnings
- Benitec Biopharma Inc. earnings per share (EPS)
- Benitec Biopharma Inc. P/E ratio
- Benitec Biopharma Inc. P/S ratio
- Benitec Biopharma Inc. P/B ratio
- Benitec Biopharma Inc. free cash flow
- Benitec Biopharma Inc. operating margin
- Benitec Biopharma Inc. dividend
- Benitec Biopharma Inc. shares outstanding
- Benitec Biopharma Inc. total debt
- Benitec Biopharma Inc. cash on hand
- Benitec Biopharma Inc. total assets
- Benitec Biopharma Inc. return on equity (ROE)
- Benitec Biopharma Inc. return on invested capital (ROIC)
Benitec Biopharma Inc. (BNTC) overview: price, valuation and scorecard
Benitec Biopharma Inc. revenue: questions and answers
What is Benitec Biopharma Inc.'s revenue?
Benitec Biopharma Inc. (BNTC) reported revenue of $75.00K in fiscal 2023 (the year ended June 30, 2023). That is 2.7% higher than the $73.00K of fiscal 2022.
What are the highest and lowest revenue figures on record for Benitec Biopharma Inc.?
Across the 5 fiscal years on record (2019–2023), the highest was $12.20M in fiscal 2019 and the lowest $59.00K in fiscal 2021.
How is Benitec Biopharma Inc.'s revenue calculated?
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
Fiscal years are named for the calendar year they end in.
Learn: revenue
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Benitec Biopharma Inc. (BNTC) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BNTC/revenue
Underlying data: the company's filings with the SEC and Yahoo Finance.